Tradestie Institutional Equity Comparison Engine
ALKS vs ARIA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ALKS Overall Edge
ALKS Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alkermes Inc. plc (ALKS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ALKS trades at 133.3x Forward P/E with 11.5% operating margin (+21.8% YoY revenue) versus ARIA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ALKS sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ALKS
ALKS 133.3x vs ARIA N/M Fwd P/E
Growth & Margin Winner
ALKS
Op Margin 11.5% vs N/A ยท YoY +21.8% vs N/A
Momentum & Technical Winner
ALKS
1Y +50.0% vs -17.0% ยท 52W Pos 68% vs 0%
Options & Structure Winner
ALKS
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (N/A IV)
ALKS
NASDAQ
Alkermes Inc. plc
Pharmaceutical Preparations
$46.53
-1.06% 1D
Market Cap
$7.9B
1M Return
+12.88%
1Y Return
+50.05%
Forward P/E
133.3x
Unified AI Score
32.1 / 100
SELL
Tech 16.0
Fund 39.0
Flow 68.0
Mom 40.0
ARIA
US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap
N/A
1M Return
-11.55%
1Y Return
-16.97%
Forward P/E
N/M
Unified AI Score
47.7 / 100
HOLD
Tech 50.0
Fund 52.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ALKS +50.05%
ARIA -16.97%
Spread: +11.16 pp (ALKS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ALKS TTM Op. Margin: 11.5%
ARIA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ALKS vs ARIA. Trailing 12-month operating profitability (ALKS 11.5% vs ARIA N/A) and valuation multiples (ALKS 133.3x vs ARIA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ALKS | ARIA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.9B | N/A | Larger Scale | ALKS |
| Trailing P/E Ratio Valuation | 133.3x | N/M | Lower Multiple | ALKS |
| Forward P/E Ratio Valuation | 133.3x | N/M | Lower Multiple | ALKS |
| Revenue Growth (YoY) Growth | +21.8% | N/A | Higher Growth | ALKS |
| Operating Margin (TTM) Profitability | 11.5% | N/A | Higher Margin | ALKS |
| Net Profit Margin Profitability | -0.0% | N/A | Higher Margin | ALKS |
| Return on Equity (ROE) Capital Efficiency | -0.0% | N/A | Higher ROE | ALKS |
| 52-Week Range Position Momentum | 68% ($27โ$56) | 0% ($21โ$27) | Stronger Trend | ALKS |
| Beta / 30D Volatility Risk Regime | 0.75ฮฒ ยท 26% Vol | 1.92ฮฒ ยท 43% Vol | Lower Realized Risk | ALKS |
| Unified Institutional Score Composite Signal | 32.1 / 100 (SELL) | 47.7 / 100 (HOLD) | Higher Composite | ARIA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ALKS vs ARIA Buy Guide
ALKS
CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
ARIA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ALKS nor ARIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.